Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models
NSE-apoE4

Posted 22 May 2005

General Information

Transgene: The apoE4 minigene consists of part of the untranslated exon 1 (from the AvrII site), the first intron, third intron and the first 6 bp of exon 2 from the human APOE gene, a fragment of human apoE cDNA contributing the entire apoE coding region, and a genomic segment representing exon 4 noncoding sequence and 112 bp of 3' untranslated region including the polyadenylation signal. There was a base change in exon 4 encoding arginine (R) in apoE4 at aa position 112.The NSE-apoE4 transgene was injected into one-cell embryos (ICR strain). NSE-apoE4 tg line was crossed with Apoe-/- mice (Taconic #APOE-M) to eliminate wild-type Apoe alleles. Then crossed with Apoe-/- mice (TJL #2052) to generate NSE-apoE4 mice that were at least 75% C57BL/6J.

Promoter: Rat neuron-specific enolase promoter

Mouse strain: Origin: C57BL/6J; Backcrossed with murine apoE-null mice, N>20

Phenotype

Neuropathological analysis

Neuronal apoE expression was widespread in the brains of these mice. Expression of apoE4 did not protected against excitotoxin (Kainic acid)-induced neuronal damage.

Behavioral

NSE-apoE4 mice showed impairments in learning a water maze task and in vertical exploratory behavior that increased with age and were seen primarily in females.

Availability

Licensing/academic distribution contact information:

Dr. Robert W. Mahley
Gladstone Institute of Neurological Disease
1650 Owens Street
San Francisco, CA 94158
Phone: 415-734-2000
Fax: 415-355-0820
Email: rmahley@gladstone.ucsf.edu

Patents: Patent Number: 6,046,381; Title: Apolipoprotein E Transgenic Mice and Assay Methods; Inventors: Mucke, L., Raber, J., Buttini, M., Mahley, R.W., Pitas, R.E.; Filing Date: 4/30/1998; Issue Date: 4/4/2000

References

Primary:

Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, Mahley RW, Mucke L. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci U S A 95(18):10914-9, 1998. Abstract.

Associated:

Buttini, M., Orth, M., Bellosta, S., Akeefe, H., Pitas, R. E., Wyss-Coray, T., Mucke, L. & Mahley, R. W. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J. Neurosci. 19, 4867-4880, 1999. Abstract

Harris FM, Brecht WJ, Xu Q, Mahley RW, Huang Y. Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J Biol Chem. 279(43):44795-801, 2004. Abstract

Brecht WJ, Harris FM, Chang S, Tesseur I, Yu GQ, Xu Q, Dee Fish J, Wyss-Coray T, Buttini M, Mucke L, Mahley RW, Huang Y. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci. 2004 Mar 10;24(10):2527-34. Abstract

Buttini M, Akeefe H, Lin C, Mahley RW, Pitas RE, Wyss-Coray T, Mucke L. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience. 2000;97(2):207-10. Abstract

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad